Wells Fargo & Company Bellerophon Therapeutics, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.76 $7,603 - $15,206	-20,009 Reduced 10.0%	180,066 $72,000
Q2 2023 Aug 15, 2023	BUY	$0.68 - $12.39 $6 - $111	9 Added 0.0%	200,075 $138,000
Q1 2023 May 12, 2023	BUY	$0.9 - $7.89 $8,100 - $71,017	9,001 Added 4.71%	200,066 $1.58 Million
Q4 2022 Feb 13, 2023	SELL	$0.67 - $1.2 $6,028 - $10,797	-8,998 Reduced 4.5%	191,065 $171,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $1.69 $6 - $10	6 Added 0.0%	200,063 $218,000

Q2 2022 Aug 12, 2022	BUY	$0.85 - $2.36 $4 - $11	5 Added 0.0%	200,057 $246,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $4.05 $118,000 - $202,500	-50,000 Reduced 20.0%	200,052 $620,000
Q3 2021 Nov 15, 2021	SELL	$3.75 - $4.86 $765 - $991	-204 Reduced 0.08%	250,052 $1.02 Million
Q2 2021 Aug 16, 2021	SELL	$3.83 - $5.65 $4,442 - $6,554	-1,160 Reduced 0.46%	250,256 $1.21 Million
Q1 2021 May 13, 2021	BUY	$5.07 - $8.27 $248,866 - $405,941	49,086 Added 24.26%	251,416 $1.31 Million
Q4 2020 Feb 09, 2021	BUY	$6.12 - $10.37 $563,615 - $955,014	92,094 Added 83.54%	202,330 $1.35 Million
Q3 2020 Nov 05, 2020	BUY	$9.27 - $13.79 $1.01 Million - $1.5 Million	108,476 Added 6163.41%	110,236 $1.12 Million
Q2 2020 Aug 13, 2020	BUY	$9.43 - $20.28 $16,455 - $35,388	1,745 Added 11633.33%	1,760 $22,000
Q1 2020 May 14, 2020	BUY	$3.39 - $18.0 $50 - $270	15 New	15 $0

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $477K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.